Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
To give you an idea of the sensitivity in the model, every 1% change in our year-over-year price erosion forecasts has a $6 billion impact on our US peak sales numbers
:max_bytes(150000):strip_icc()/VWH-GettyImages-1793641166-3555361b354b4d0292bdb0cd34c6f241.jpg)
Key points: In the only head-to-head trial, Wegovy produced 15.8% weight loss compared with 6.4% for Saxenda over the same 68-week period Wegovy 7.2 mg (approved January 2026) produces even greater results at 20.7% average weight loss Real-world data from Second Nature shows 19.1% weight loss with semaglutide when combined with behavioural support Semaglutide participants were nearly three times more likely to achieve at least 10% weight loss than liraglutide participants Side effects and tolerability Both medications share a similar side-effect profile, predominantly affecting the gastrointestinal tract
Presented for research literature review only Drge W et al
Glucose-Dependent Insulin Secretion Semaglutide enhances insulin release only when glucose is elevated, thereby improving glycemic control and reducing the risk of hypoglycemia
US$ 23.14
US$ 25.63
US$ 27.73
US$ 22.85
US$ 23.82
US$ 20.48
US$ 24.42
US$ 26.18
US$ 20.83
US$ 20.46
US$ 27.15
US$ 28.23
